Cargando…

Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels

We investigated whether serum hs-CRP levels predict the efficacy of atrial fibrillation (AF) treated with atorvastatin. Bibliographic databases were exhaustively searched for studies relevant to the research topic. Newcastle-Ottawa Scale (NOS) criteria, combined with the Quality Assessment of Diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Fang-Cheng, Li, Xi-Dong, Sun, Shao-Xia, Shi, Ming-Yu, Xue, Feng-Hua, Teng, Shi-Chao, Jiang, Li, Zhu, Jing, Yin, Feng, Gu, Hong-Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502280/ https://www.ncbi.nlm.nih.gov/pubmed/26229958 http://dx.doi.org/10.1155/2015/402481

Ejemplares similares

Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing
por: Yang, Qian, et al.
Publicado: (2016)

The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials
por: Yang, Qian, et al.
Publicado: (2014)

Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism
por: Zheng, Jie, et al.
Publicado: (2021)

Reactive oxygen species mediated oxidative stress links diabetes and atrial fibrillation
por: Liang, Xue, et al.
Publicado: (2018)

Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
por: Škorňová, Ingrid, et al.
Publicado: (2021)

Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry)
por: Carrascal, Yolanda, et al.
Publicado: (2016)

Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia
por: JIN, DAOQUN, et al.
Publicado: (2012)

Platelet reactivity in patients with atrial fibrillation
por: Ozmen, Namık, et al.
Publicado: (2016)

Relationships of High-sensitive C-reactive Protein and P-wave Dispersion in Lone Atrial Fibrillation
por: Zheng, Li-Hui, et al.
Publicado: (2015)

Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study
por: Tanaka, Mari, et al.
Publicado: (2021)

Association of Serum Omentin-1 Concentrations with the Presence of Atrial Fibrillation
por: Tao, Sha, et al.
Publicado: (2016)

Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study
por: Zhong, Xia, et al.
Publicado: (2022)

Association between serum apolipoprotein B and atrial fibrillation: a case–control study
por: Zhong, Xia, et al.
Publicado: (2022)

The Impact of Left Atrial Size in Catheter Ablation of Atrial Fibrillation Using Remote Magnetic Navigation
por: Liu, Xiao-yu, et al.
Publicado: (2018)

Relationship between serum lipid levels and ischemic stroke in patients with atrial fibrillation: a nested case–control study based on the China Atrial Fibrillation Registry
por: Li, Fei, et al.
Publicado: (2021)

Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
por: Sumiyoshi, Hironobu, et al.
Publicado: (2023)

Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2010)

Role of inflammation in the initiation and maintenance of atrial fibrillation and the protective effect of atorvastatin in a goat model of aseptic pericarditis
por: ZHANG, YE, et al.
Publicado: (2015)

High sensitivity C reactive protein levels and atrial fibrillation recurrence after catheter ablation for atrial fibrillation: A systematic review and meta‐analysis
por: Jaroonpipatkul, Surachat, et al.
Publicado: (2023)

Erratum: Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study
por: Zhong, Xia, et al.
Publicado: (2022)

Baroreflex Sensitivity in Patients With Atrial Fibrillation
por: Miyoshi, Miho, et al.
Publicado: (2020)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
por: Dong, Youzheng, et al.
Publicado: (2022)

Relationship between serum angiopoietin-like 4 levels and recurrence of atrial fibrillation
por: Ning, Zhongping, et al.
Publicado: (2021)

Association of Serum Biomarkers and Cardiac Inflammation in Patients With Atrial Fibrillation: Identification by Positron Emission Tomography
por: Chen, Bi-Xi, et al.
Publicado: (2021)

Fibrosis in Atrial Fibrillation – Role of Reactive Species and MPO
por: Friedrichs, Kai, et al.
Publicado: (2012)

Significant Increase in C-Reactive Protein and Serum Amyloid A in the Early Hours of Paroxysmal Atrial Fibrillation
por: Negreva, Mariya, et al.
Publicado: (2016)

The value of left atrial longitudinal strain in evaluating left atrial appendage spontaneous echo contrast in non-valvular atrial fibrillation
por: Ma, Chang sheng, et al.
Publicado: (2023)

Platelet Reactivity Is Independent of Left Atrial Wall Deformation in Patients with Atrial Fibrillation
por: Procter, Nathan, et al.
Publicado: (2016)

Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation
por: Zhao, Fei, et al.
Publicado: (2014)

A case–control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation
por: Zhong, Xia, et al.
Publicado: (2022)

Serum level of transforming growth factor beta 1 is associated with left atrial voltage in patients with chronic atrial fibrillation
por: Zhao, Shilu, et al.
Publicado: (2017)

Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study
por: Li, Zhi-Zhao, et al.
Publicado: (2022)

Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy
por: Urbano, Francesca, et al.
Publicado: (2019)

Associations of big endothelin-1 and C-reactive protein in atrial fibrillation
por: Zheng, Li-Hui, et al.
Publicado: (2016)

Serum cholesterol levels and postoperative atrial fibrillation
por: Aydin, Mehmet, et al.
Publicado: (2014)

Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis
por: Li, Xiaoxia, et al.
Publicado: (2019)

Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case–control study
por: Zhong, Xia, et al.
Publicado: (2023)

Effects of febuxostat on atrial remodeling in a rabbit model of atrial fibrillation induced by rapid atrial pacing
por: Fan, Yong-Yan, et al.
Publicado: (2019)

Characteristics of Atrial Fibrillation Patients Suffering Esophageal Injury Caused by Ablation for Atrial Fibrillation
por: Zhang, Pei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_20kgnndfaoouq27ing544502cs